INSERRA, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 2.422
EU - Europa 1.148
AS - Asia 869
SA - Sud America 142
AF - Africa 121
OC - Oceania 6
Totale 4.708
Nazione #
US - Stati Uniti d'America 2.347
SG - Singapore 499
IT - Italia 357
CN - Cina 296
IE - Irlanda 286
DE - Germania 158
UA - Ucraina 137
BR - Brasile 136
RU - Federazione Russa 86
CI - Costa d'Avorio 73
CA - Canada 70
SN - Senegal 37
IN - India 31
SE - Svezia 26
FR - Francia 22
GB - Regno Unito 22
VN - Vietnam 11
AT - Austria 8
CH - Svizzera 8
NL - Olanda 7
FI - Finlandia 6
ZA - Sudafrica 6
AU - Australia 5
BE - Belgio 5
GR - Grecia 5
UZ - Uzbekistan 5
PL - Polonia 4
TR - Turchia 4
IQ - Iraq 3
JP - Giappone 3
LB - Libano 3
MX - Messico 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
HK - Hong Kong 2
IL - Israele 2
IR - Iran 2
MA - Marocco 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
ID - Indonesia 1
JM - Giamaica 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.708
Città #
Santa Clara 478
Chandler 401
Dublin 286
Singapore 266
Houston 158
Jacksonville 156
Chicago 144
Boardman 110
Bremen 82
Lawrence 82
Cambridge 81
Andover 80
Abidjan 73
Nanjing 72
Ashburn 61
Des Moines 52
Toronto 52
Grafing 49
Catania 47
Civitanova Marche 43
Beijing 37
Dakar 37
Wilmington 36
Nanchang 29
Saint Petersburg 23
San Mateo 21
Shenyang 20
Council Bluffs 17
The Dalles 17
Civitavecchia 16
Hebei 16
Jiaxing 15
Ottawa 15
Kochi 14
Tianjin 13
Vicenza 13
Moscow 12
Changsha 11
Ann Arbor 10
Rome 10
Dong Ket 9
Pune 7
San Giuliano Milanese 7
São Paulo 7
Modena 6
Padova 6
Aci Catena 5
Brussels 5
Guangzhou 5
Jinan 5
Los Angeles 5
Messina 5
Milan 5
Munich 5
Norwalk 5
Rio de Janeiro 5
Seattle 5
Brooklyn 4
Falls Church 4
Helsinki 4
Lanzhou 4
Liberty Lake 4
Ludwigshafen 4
Manzano 4
Ningbo 4
Shanghai 4
Washington 4
Zhengzhou 4
Belo Horizonte 3
Bernareggio 3
Brasília 3
Canberra 3
Fuzhou 3
Huddersfield 3
Johannesburg 3
Kunming 3
Marano di Napoli 3
Modica 3
Oliena 3
Palermo 3
Phoenix 3
Reigate 3
Tokyo 3
Trecastagni 3
Warsaw 3
Ardabil 2
Atlanta 2
Baghdad 2
Baku 2
Barletta 2
Brno 2
Camerata Picena 2
Campinas 2
Cape Town 2
Dallas 2
Den Haag 2
Fairfield 2
Frankfurt Am Main 2
Fremont 2
Garanhuns 2
Totale 3.377
Nome #
ASSOCIATION OF IRRITABLE BOWEL SYNDROME WITH NON-EROSIVE REFLUX DISEASE 239
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 107
La Fenoverina nel trattamento della sindrome del colon irritabile 104
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CELIAC DISEASE IN EASTERN SICILY AREA 104
Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease? 102
Uso della mesalazina e del beclometasone dipropionato nella pancolite ulcerosa. Descrizione di un caso clinico 91
Crohn's disease during pregnancy 84
Colorectal Endoscopic Polipectomy: A Retrospective Study 83
Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy 82
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 80
Arterial structure and function in inflammatory bowel disease. 79
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 79
Arterial stiffness is increased in patients with inflammatory bowel disease 78
685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 78
Gastrointestinal complications after kidney transplantation 78
CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN INFLAMMATORY BOWEL DISEASE 77
Caso clinico: Una rettorragia in un giovane ragazzo 77
RISK FACTORS OF COLORECTAL POLYPS IN MALE POPULATION OF SOUTH-EASTERN SICILY 75
Linfoma non-Hodgkin ad esordio digiunale (stadio II E 2). Follow-up a medio termine di un caso trattato con chirurgia e terapia sistemica 74
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 72
EVALUATION OF CROHN’S DISEASE ACTIVITY BY DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 72
Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis 70
Irritable Bowel syndrome: subgroups and relationship with gastroesophageal reflux disease 70
PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE INCREASED ARTERIAL STIFFNESS 69
A case of osseous metaplasia in the stomach 67
Overlapping of gastroesophageal reflux disease and irritable Bowel syndrome 67
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CELIAC DISEASE IN EASTERN SICILY AREA 66
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 66
Pepsinogen A, Pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics 65
Alterazioni carotidee in corso di insufficienza renale cronica 65
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 65
Arterial stiffness in patients with inflammatory bowel diseases 64
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 64
AORTIC-BRACHIAL STIFFNESS MISMATCH STARTS EARLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE 64
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 62
Clinical significance of cytomegalovirus (CMV) infection in inflammatory bowel disease 61
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 59
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2 59
Crohn's disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index 58
Arterial stiffness is increased in inflammatory bowel disease, dependent upon inflammation and reduced by immunomodulatory drugs 58
Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing 57
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 56
P.01.15 EVALUATION OF CROHN'S DISEASE ACTIVITY BY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 56
Prevalence of Inflammatory Bowel Disease in patients with celiac disease 55
Protection By Copper (Cu++) Against Ethanol-Induced Gastric Mucosal Injury In The Rat 55
P.17.17 RISK FACTORS OF COLORECTAL POLYPS IN MALE POPULATION OF SOUTH-EASTERN SICILY 55
La clebopride nel trattamento della dispepsia funzionale: studio clinico in doppio cieco v/s placebo 52
Subclinical atherosclerosis in patients with inflammatory bowel diseases: A systematic review and meta-analysis 51
Hiatal Hernia And Reflux Esophagitis: An Endoscopic Study 51
Su1339 Ulcerative Colitis (UC) Diagnosed Over Age 65 Years -An IG-IBD Study 51
Inflammation and aortic stiffness: An individual participant data meta-analysis in patients with inflammatory bowel disease 50
Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study 49
PREVALENZA DI HHV6 NELLE MALATTIE INFIAMMATORIE DELL’INTESTINO 49
Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox 48
COMPARISON OF ESTIMATING GFR FORMULAS IN ELDERLY 48
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine. A single-blind randomized controlled trial 47
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease 46
P660. Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 45
LEWIS ANTIGEN EXPRESSION AND OTHER PATHOGENIC FACTORS IN THE PRESENCE OF ATROPHIC CHRONIC GASTRITIS IN A EUROPEAN POPULATION 44
P.10.14 ASSOCIATION OF IRRITABLE BOWEL SYNDROME WITH NON-EROSIVE REFLUX DISEASE 44
Estimated GFR and renal sinus section area are independent predictors of renal dysfunction in elderly 42
Prevalenza di HHV6 nelle malattie infiammatorie dell’intestino 41
P.05.4 ARTERIAL STIFFNESS IS INCREASED IN IBD PATIENTS 41
Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs 41
Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study 40
Inflammatory bowel diseases and pericarditis 39
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study 37
Omeprazole vs. ranitidine in short-term treatment of Helicobacter pylori positive duodenal ulcer patients 37
P181 Diagnostic performance of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) in the evaluation of stenosis and endoscopic recurrence in Crohn's disease 36
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 36
P.07.1 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) ARE LESS LIKELY TO PERSIST ON ANTI-TNF THERAPY COMPARED WITH YOUNGER PATIENTS. DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD) 34
Early anti-tumor necrosis factor therapy reduces aortic stiffness in inflammatory bowel disease: a multicentre longitudinal study 34
OC.02.3 A REAL LIFE COMPARISON OF THE EFFECTIVENESS OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTRE EXPERIENCE FROM A REGIONAL NETWORK FOR INFLAMMATORY BOWEL DISEASE 33
OC.02.4 THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE 30
P577 A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s disease 29
P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis 28
OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety 28
P545 Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 27
OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS 26
Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 25
P539 Does a change in therapeutic approach modify outcome in IBD patients? A comparison between two cohorts 2004–2007 and 2010–2013 24
P412 The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy 24
P.05.22 INFLAMMATORY BOWEL DISEASES AND PERICARDITIS 22
Totale 4.897
Categoria #
all - tutte 18.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 0 0 0 0 0 0 0 0 0 0 49 26
2020/2021417 24 30 34 2 110 13 39 7 87 17 34 20
2021/2022575 68 86 4 15 91 5 88 18 36 1 18 145
2022/20231.116 91 69 26 179 93 181 4 190 244 5 27 7
2023/2024392 27 61 21 13 17 73 22 28 3 7 85 35
2024/20251.580 21 250 106 83 381 232 67 66 152 160 62 0
Totale 4.897